Keratitis–ichthyosis–deafness syndrome
(Redirected from KID/HID syndrome)
Keratitis–ichthyosis–deafness syndrome (KID syndrome) is a rare genetic disorder characterized by the triad of keratitis, ichthyosis, and deafness. It is typically inherited in an autosomal dominant manner and is caused by mutations in the GJB2 gene, which encodes the protein connexin 26.
Clinical Features[edit | edit source]
Individuals with KID syndrome present with a combination of the following symptoms:
- **Keratitis**: Inflammation of the cornea leading to photophobia, corneal opacities, and potential vision loss.
- **Ichthyosis**: Thickened, scaly skin that may be present at birth or develop in early childhood. The skin changes are often most prominent on the face, scalp, and extremities.
- **Deafness**: Sensorineural hearing loss that is typically present from birth.
Genetics[edit | edit source]
KID syndrome is caused by mutations in the GJB2 gene, which is located on chromosome 13q11-q12. The GJB2 gene encodes the protein connexin 26, which is involved in the formation of gap junctions that facilitate cell-to-cell communication. Mutations in this gene disrupt normal cellular communication, leading to the clinical manifestations of the syndrome.
Diagnosis[edit | edit source]
The diagnosis of KID syndrome is based on clinical findings and can be confirmed by genetic testing to identify mutations in the GJB2 gene. Ophthalmologic and audiologic evaluations are essential for assessing the extent of keratitis and hearing loss, respectively.
Management[edit | edit source]
Management of KID syndrome is multidisciplinary and may include:
- **Ophthalmologic care**: Regular monitoring and treatment of keratitis to prevent vision loss.
- **Dermatologic care**: Use of emollients and keratolytic agents to manage ichthyosis.
- **Audiologic care**: Hearing aids or cochlear implants to address hearing loss.
- **Genetic counseling**: For affected individuals and their families to understand the inheritance pattern and implications.
Prognosis[edit | edit source]
The prognosis for individuals with KID syndrome varies depending on the severity of the symptoms. Early diagnosis and appropriate management can improve the quality of life for affected individuals.
Related Pages[edit | edit source]
Categories[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD